SARS-CoV-2 infection relaxes peripheral B cell tolerance is a research paper published in The Journal of Experimental Medicine (2022). On theSindex it has a DataRank of 0.510. It has been cited 29 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.510
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Health
Grant: R01 AI136534
National Institute of Health
Grant: AI124474
National Institute of Health
Grant: AI131639
NIH/NCATS Colorado CTSA
Grant: UL1 TR002535
BLRD VA
Grant: I01 BX003863
NIAID NIH HHS
Grant: R21 AI156232
NHLBI NIH HHS
Grant: R35 HL140039
NIAID NIH HHS
Grant: R21 AI131639
NIAID NIH HHS
Grant: T32 AI007405
NIAID NIH HHS
Grant: R01 AI152535
NIAID NIH HHS
Grant: R01 AI124474
NHLBI NIH HHS
Grant: K08 HL141648
NIAID NIH HHS
Grant: R01 AI153724
National Institutes of Health
Grant: 5R01AI124474-02
Studies of human B cell tolerance, from a humanized mouse model to human beings
National Institutes of Health
Grant: 3UL1TR002535-03S1
NIH Prior Approval Process Professional
National Institutes of Health
Grant: 1R21AI131639-01
Testing an alternative model of central B cell tolerance
National Institutes of Health
Grant: 5R01AI136534-03
Humoral Immunity by Anergic B cells
FWCI
2.51
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals